Is Oncolys BioPharma Inc. stock a buy?

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Oncolys BioPharma Inc. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY1 994.00, you would have made a loss of JPY-1 399.00 per share or -70.16%

Yes, the average daily trading liquidity for Oncolys BioPharma Inc. is JPY467 860 thousand. You should therefore be able to get in and out of your positions relatively fast.

Oncolys BioPharma Inc. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.04, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Oncolys BioPharma Inc. to be high [0.85 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.